COVID-19 Resources

Articles

	Metformin and risk of mortality in patients hospitalized with COVID-19: a retrospective cohort analysis
	Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission
	Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized with COVID-19
	Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19
	Myocardial injury in adults hospitalized with COVID-19
	Sodium-glucose co-transporter-2 inhibitors and susceptibility to COVID-19: a population-based retrospective cohort study
	Early elevation of FIB-4 liver fibrosis score is associated with adverse outcomes among patients with COVID-19
	Drug-Induced arrhythmias: a scientific statement from the American Heart Association
	DPP-4 inhibitor sitagliptin can reduce mortality in T2DM patients with COVID-19
	Arrhythmias and COVID-19: a review
	Hydroxychloroquine/azithromycin therapy and QT prolongation in hospitalized patients with COVID-19
	Feasibility of inpatient CGM during the COVID-19 pandemic: early experience
	SGLT2 inhibition during the COVID-19 epidemic: friend or foe?
	Covid-19 and disparities in nutrition and obesity
	Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
	Caring for older adults with diabetes during the COVID-19 pandemic
	Innovative transthoracic echocardiographic imaging on prone ventilated patients with COVID-19
	Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19
	Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes
	Diabetic ketoacidosis in COVID-19: unique concerns and considerations
	COVID-19 presenting as Takotsubo cardiomyopathy complicated with atrial fibrillation
	Cardiovascular complications of COVID-19: pharmacotherapy perspective
	The close relationship between COVID-19 and out-of-hospital cardiac arrests
	Hyperglycemia at admission can increase mortality risk in COVID-19 patients
	COVID-19 in people living with diabetes: an international consensus
	Cholesterol in relation to COVID-19: should we care about it?
	COVID-19 and cardiac arrhythmias
	COVID-19 in people with diabetes: urgently needed lessons from early reports
	Association of ACE inhibitor or ARB use with COVID-19 diagnosis and mortality
	Approach to acute CV complications in COVID-19 infection
	International registry of new-onset diabetes in COVID-19
	Severe obesity associated with higher in-hospital mortality in patients with COVID-19
	Exposure to DPP-4 inhibitors in patients with type 2 diabetes and COVID-19
	A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic
	Cardiac manifestations of COVID-19 by echocardiography
	Hydroxychloroquine in patients with diabetes: risk and benefits in the setting of COVID-19
	Obesity could shift severe COVID-19 disease to younger ages
	Remdesivir for the treatment of COVID-19 - preliminary report
	No evidence to abandon RAAS inhibitors in COVID-19
	Coronavirus infections and Type 2 Diabetes—shared pathways with therapeutic implications
	A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
	Mild or Moderate Covid-19
	Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
	Collateral Effect of Covid-19 on Stroke Evaluation in the United States
	COVID-19 and Racial/Ethnic Disparities
	Bariatric and metabolic surgery guidance in the era of COVID-19
	Cardiovascular manifestations and treatment considerations in Covid-19
	Top 10 tips for successfully implementing a diabetes telehealth program
	Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States
	Compassionate use of remdesivir for patients with severe Covid-19
	Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
	Remdesivir Authorized for Emergency Use in COVID-19 by the FDA
	Risk of QT Interval Prolongation Associated with Use of Hydroxychloroquine With or Without Azithromycin Among Hospitalized Patients Testing Positive for COVID-19
	Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for COVID-19
	COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way
	Practical recommendations for the management of diabetes in patients with COVID-19
	Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
	Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
	Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
	The Variety of Cardiovascular Presentations of COVID-19
	The Restructuring of Structural Heart Disease Practice During the Covid-19 Pandemic
	ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak
	Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
	Mental Health and the Covid-19 Pandemic
	Developing Covid-19 Vaccines at Pandemic Speed
	Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
	Compassionate Use of Remdesivir for Patients with Severe Covid-19
	Are Patients With Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection?
	Our Response to COVID-19 as Endocrinologists and Diabetologists
	Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
	Virtual health care in the era of COVID-19
	Convalescent Plasma for the Prevention and Treatment of COVID-19
	COVID-19 and the Heart
	Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
	World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
	This article discuss the emergence of coronaviruses in two decades. Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19
	This review explores the clinical characteristics of COVID-19 Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
	The articles discuss the significance of social distancing interventions against COVID-19. Scientific and ethical basis for social-distancing interventions against COVID-19
	This Article reviews the treatment approaches for COVID-19 COVID-19: combining antiviral and anti-inflammatory treatments
	COVID-19 and the cardiovascular system
	Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Expert Perspectives

The impact of COVID-19 in patients with diabetes

In this podcast, CMHC chair Dr. Anne Peters, Professor of Medicine and Director of Clinical Diabetes Programs at the University of Southern California in LA, discusses the impact of COVID-19 in patients with diabetes

Recorded March 25, 2020

Listen Now

"COVID-19 and Cardiovascular Disease" with Clyde Yancy, MD

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.

Recorded April 1, 2020

Listen Now

"COVID-19, cardiac injury, and statin therapy" with Christie Ballantyne, MD

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.

Recorded March 25, 2020

Listen Now

The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19

Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.

Recorded 3/26/2020

Listen Now

Resources for Clinicians

Resources for Cardiometabolic Patients

Do The Five How to Protect Yourself What To Do if You are Sick Coronavirus (COVID-19) Symptoms AHA: What people with high blood pressure need to know about COVID-19

Are you at Higher Risk for Severe Illness? Guidance from the World Health Organization on coronavirus disease (COVID-19) overview, prevention, and symptoms Guidance from the American College of Cardiology and the American Heart Association for patients with heart disease Guidance from the American Diabetes Association for patients with diabetes

Do the five

DOWNLOAD

Symptoms of Coronavirus

DOWNLOAD

#Istayathome

DOWNLOAD

What to do if you are sick

DOWNLOAD

Blog

THE SILENT SUB-EPIDEMIC: THE RISING POPULATION OF PATIENTS FORGOING NEEDED MEDICAL CAREABLO

MAY 6, 2020

With the novel coronavirus (COVID-19) outbreak taking over hospitals across the country and globe, elective procedures postponed, and non-emergency visits cancelled, many hospital units and healthcare facilities have been entirely transformed into specialized COVID-19 units. Many others, however, have retained most of their previous...

THE IMPACT OF COVID-19 ON THE CARDIOMETABOLIC HEALTHCARE COMMUNITY

APRIL 30, 2020

The COVID-19 pandemic has resulted in significant morbidity and mortality across the world, and the numbers continue to rise. Amid this pandemic, clinicians still have to diagnose, assess, and treat patients for both COVID-19 and non-COVID-19 medical issues. This extremely contagious disease has brought upon new realities and posed...

IMPLEMENTING TELEHEALTH INTO YOUR CARDIOLOGY PRACTICE

APRIL 4, 2020

In light of the novel coronavirus (COVID-19) outbreak many medical practices have been forced to conduct their business online via newly implemented or existing telehealth programs. Previously used as an adjunct to in-person care, telecardiology is set to replace the majority of outpatient cardiac clinic visits for the foreseeable future.

CHANGES TO CARDIOLOGY PRACTICES DURING THE COVID-19 OUTBREAK

MARCH 26, 2020

Cardiologists and medical professionals across specialties are currently being faced with continuously evolving directives that aim to respond to developments in the novel coronavirus outbreak; they aim to minimize the risk of exposure, protect vulnerable demographics, and ensure the healthcare system can handle rapidly increasing demands.

Cardiometabolic Health

COVID-19 Resource Hub

Cardiometabolic Health

COVID-19 Resource Hub

Articles

Expert Perspectives

The impact of COVID-19 in patients with diabetes

"COVID-19 and Cardiovascular Disease" with Clyde Yancy, MD

"COVID-19, cardiac injury, and statin therapy" with Christie Ballantyne, MD

The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19

Resources for Clinicians

World Health Organization:

Centers for Disease Control and Prevention (CDC)

STATE-WISE

Other resources